MY01 Welcomes Joe Kiani to Pave the Way in Patient Health

Author: Addison Perry Updated: 09-08-2025 11:24 AM

MY01 Welcomes Joe Kiani as Investor and Board Member

MY01, a pioneering medical technology company specializing in limb perfusion injury diagnostics, has announced an exciting new development. Joe Kiani, recognized globally for his contributions to medical innovation and as the founder of Masimo, has invested in MY01 and will be joining their Board of Directors.

A New Chapter in Patient Monitoring

Charles Allan, CEO of MY01, expressed enthusiasm about Kiani's involvement, stating, "We are excited to welcome Joe Kiani as an investor and board member at MY01. His impressive background in innovating patient monitoring technologies and dedication to enhancing patient lives perfectly aligns with our mission." Together, Kiani and MY01 aim to push the boundaries of limb health with their groundbreaking continuous perfusion sensing technology (CPST).

Transforming Healthcare Delivery

Kiani's reputation stems from his founding of Masimo, a leader in medical technology known for its revolutionary non-invasive monitoring solutions like pulse oximetry. These innovations have redefined care delivery and significantly improved patient outcomes, saving countless lives. In addition to his work with Masimo, he established the Patient Safety Movement Foundation, advocating for the elimination of preventable healthcare deaths.

Building on a Vision of Innovation

Kiani highlighted the significance of MY01's CPST platform, noting, "MY01's breakthrough CPST platform has been shown to help clinicians save limbs and lives by detecting lack of limb perfusion after an injury. Over one million limb injuries occur annually, and without this technology, clinicians face challenging decisions with limited data. CPST is indeed a game changer." His commitment to supporting MY01 reflects a shared vision to improve patient lives globally.

Advancements in Trauma Care

This strategic investment in MY01 allows the company to further develop its CPST platform, which is designed to minimize variations in orthopedic and vascular trauma care. Additionally, MY01 is set to lead advancements in cardiogenic shock monitoring, providing healthcare professionals with tools to enhance outcomes for critically ill patients.

About MY01

Founded in 2019, MY01 seeks to create a future where all diseases can be quantitatively assessed, resulting in tailored care for every patient. The company's CPST platform is transforming trauma care by turning complex biological data into immediate, actionable insights. This innovative approach not only decreases care variability but also aids hospitals in optimizing resource allocation. MY01 is actively changing the healthcare landscape in multiple regions, including the USA, Europe, and Canada.

Media Inquiries

For further information, please contact Interdependence Public Relations at (949) 777-2468.

Frequently Asked Questions

Who is Joe Kiani?

Joe Kiani is the founder of Masimo, known for his groundbreaking work in medical technology and his new role at MY01 as an investor and board member.

What is the CPST platform?

The Continuous Perfusion Sensing Technology (CPST) platform developed by MY01 helps detect perfusion issues in limbs, aiding in timely medical intervention.

How will Joe Kiani's involvement benefit MY01?

Kiani's extensive experience and innovation in patient monitoring will enhance MY01's capabilities and drive forward its mission of improving healthcare delivery.

When was MY01 founded?

MY01 was founded in 2019 with the aim of revolutionizing how diseases are monitored and treated, providing personalized care solutions.

Where is MY01 operational?

MY01 operates in the USA, Europe, and Canada, aiming to set new standards in healthcare practices globally.

About The Author

Hello, I'm 30-year-old financial writer and expert Addison Perry, and I love to simplify the intricacies of the financial industry. I've committed myself over the years to deciphering the subtleties of investing techniques and economic trends and converting them into doable guidance that anybody can use. My goal with writings and books is to make money interesting and approachable so that readers may take charge of their financial futures.

My enthusiasm to empowerment and education has propelled me through my career in finance. I write because I think that everyone should be able to make educated financial decisions, and I try to provide that. Regardless of experience level with investing, my work is intended to provide insightful analysis and practical advice to enable you to thrive in the always changing financial environment. I appreciate you traveling with me toward success and financial literacy.

Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.